Uganda's experience in Ebola virus disease outbreak preparedness, 2018-2019.

BACKGROUND: Since the declaration of the 10th Ebola Virus Disease (EVD) outbreak in DRC on 1st Aug 2018, several neighboring countries have been developing and implementing preparedness efforts to prevent EVD cross-border transmission to enable timely detection, investigation, and response in the event of a confirmed EVD outbreak in the country. We describe Uganda's experience in EVD preparedness. RESULTS: On 4 August 2018, the Uganda Ministry of Health (MoH) activated the Public Health Emergency Operations Centre (PHEOC) and the National Task Force (NTF) for public health emergencies to plan, guide, and coordinate EVD preparedness in the country. The NTF selected an Incident Management Team (IMT), constituting a National Rapid Response Team (NRRT) that supported activation of the District Task Forces (DTFs) and District Rapid Response Teams (DRRTs) that jointly assessed levels of preparedness in 30 designated high-risk districts representing category 1 (20 districts) and category 2 (10 districts). The MoH, with technical guidance from the World Health Organisation (WHO), led EVD preparedness activities and worked together with other ministries and partner organisations to enhance community-based surveillance systems, develop and disseminate risk communication messages, engage communities, reinforce EVD screening and infection prevention measures at Points of Entry (PoEs) and in high-risk health facilities, construct and equip EVD isolation and treatment units, and establish coordination and procurement mechanisms. CONCLUSION: As of 31 May 2019, there was no confirmed case of EVD as Uganda has continued to make significant and verifiable progress in EVD preparedness. There is a need to sustain these efforts, not only in EVD preparedness but also across the entire spectrum of a multi-hazard framework. These efforts strengthen country capacity and compel the country to avail resources for preparedness and management of incidents at the source while effectively cutting costs of using a "fire-fighting" approach during public health emergencies

Continental concerted efforts to control the seventh outbreak of Ebola Virus Disease in Uganda: the first 90 days of the response

On 20th September 2022, Uganda declared the 7th outbreak of Ebola virus disease (EVD) caused by the Sudan Ebola strain following the confirmation of a case admitted at Mubende Regional Referral Hospital. Upon confirmation, the Government of Uganda immediately activated the national incident management system to initiate response activities. Additionally, a multi-country emergency stakeholder meeting was held in Kampala; convening Ministers of Health from neighbouring Member States to undertake cross-border preparedness and response actions. The outbreak spanned 69 days and recorded a total of 164 cases (142 confirmed, 22 probable), 87 recoveries and 77 deaths (case fatality ratio of 47%). Nine out of 136 districts were affected with transmission taking place in 5 districts but spilling over in 4 districts without secondary transmission. As part of the response the Government was able to galvanise robust community mobilisation and initiated assessment of medical counter measures including therapeutics, new diagnostics and vaccines. This paper highlights the response actions put in place that contributed to the containment of this outbreak in addition to the challenges faced with a special focus on key recommendations for better control of future outbreaks

New filovirus disease classification and nomenclature.

The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly increased accumulation of human genotypic, phenotypic and clinical data, and improved our understanding of the spectrum of clinical manifestations. As a result, the WHO disease classification of EVD underwent major revision

Community Mobilization Through Facilitated Participatory Learning and Action Groups for Maternal and Newborn Health in Buikwe District

The Mother Conference and Reunion Presentations, 2018Background This project tested the Participatory Learning Action (PLA) cycle in mobilizing the community for improved maternal and newborn health. The project, promoted by the World Health Organization highlighted the importance of health promotion interventions that strengthen individual, family, and community capacity to contribute to improved health while addressing the quality of care in facilities in Buikwe District. Community mobilization was realized through facilitated participatory learning and action (PLA) cycles with women’s groups in rural settings with low access to maternal health services. Community mobilization through facilitated PLA cycles work by building the capacities of communities to organize and take action to address the social determinants of health that underpin maternal and newborn health. Objective The study aimed at reviewing the feasibility of community mobilization through facilitated PLA cycles for improved maternal and newborn health in Buikwe district Methods The PLA cycle follows a four- phase approach that involves joint efforts in identifying problems, solutions, implementing and assessing program impact together. Ten women from two sub-counties in Buikwe received training in the implementation of the PLA cycle within their communities. These facilitators then led women’s groups in utilising the PLA cycle to identify and address maternal and newborn health challenges in their communities Results A total of 15 women groups were formed which utilised the four phase PLA cycle in identifying and addressing maternal and newborn health challenges in Buikwe district. They generated several local health solutions and brought about an increased demand for maternal and newborn health services. Conclusion The PLA guide is an empowerment and advocacy tool for improved maternal and newborn Health. However, the integrated nature of this approach necessitates an understanding of priorities set in mobilizing communities, the role played by local leadership and the resources needed for improved maternal and newborn health

Questions de monnaie

Dans les sociétés exotiques que l'anthropologie étudie, on constate l'existence de systèmes et de moyens de paiement qu'on pourrait appeler monétaires, mais qui débordent largement le sens restreint que les économistes donnent au concept de monnaie. Une «ressemblance de famille» existe certes entre les monnaies de coquillage mélanésiennes, par exemple, et la monnaie abstraite de la société de marchandise, mais ces monnaies exotiques servent autant à l'achat de biens qu'au paiement d'obligati..

Not Available

Not AvailableThe aim of this educational review is to provide practical information on the hardware, methodology, and the hands on application of chlorophyll (Chl) a fluorescence technology. We present the paper in a question and answer format like frequently asked questions. Although nearly all information on the application of Chl a fluorescence can be found in the literature, it is not always easily accessible. This paper is primarily aimed at scientists who have some experience with the application of Chl a fluorescence but are still in the process of discovering what it all means and how it can be used. Topics discussed are (among other things) the kind of information that can be obtained using different fluorescence techniques, the interpretation of Chl a fluorescence signals, specific applications of these techniques, and practical advice on different subjects, such as on the length of dark adaptation before measurement of the Chl a fluorescence transient. The paper also provides the physiological background for some of the applied procedures. It also serves as a source of reference for experienced scientists.Not Availabl

New filovirus disease classification and nomenclature

The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly increased accumulation of human genotypic, phenotypic and clinical data, and improved our understanding of the spectrum of clinical manifestations. As a result, the WHO disease classification of EVD underwent major revision.Federal funds from the National Cancer Institute, National Institutes of Health (NIH), under Contract No. HHSN261200800001E (I.C.). G.I. is grateful for support from the Italian Ministry of Health, grant Ricerca Corrente, Research programme n.1. The UK Public Health Rapid Support Team (D.G.B.) is funded by the UK Department of Health and Social Care.https://www.nature.com/nrmicrohj2020Veterinary Tropical Disease